0001209191-23-031074.txt : 20230519
0001209191-23-031074.hdr.sgml : 20230519
20230519170022
ACCESSION NUMBER: 0001209191-23-031074
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230518
FILED AS OF DATE: 20230519
DATE AS OF CHANGE: 20230519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brainard Diana
CENTRAL INDEX KEY: 0001818070
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39409
FILM NUMBER: 23941241
MAIL ADDRESS:
STREET 1: C/O ALLOVIR, INC.
STREET 2: 139 MAIN STREET, SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allovir, Inc.
CENTRAL INDEX KEY: 0001754068
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 831971007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (617) 433-2605
MAIL ADDRESS:
STREET 1: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: ViraCyte, Inc.
DATE OF NAME CHANGE: 20180924
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-18
0
0001754068
Allovir, Inc.
ALVR
0001818070
Brainard Diana
C/O ALLOVIR, INC.
1100 WINTER STREET
WALTHAM
MA
02451
1
1
0
0
Chief Executive Officer
1
Common Stock
2023-05-18
4
S
0
4536
4.214
D
916628
D
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.04 to $4.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
/s/ Brett Hagen, as Attorney-in-Fact
2023-05-19